uniQure

@uniQure_NV

uniQure is delivering on the promise of gene therapy - single treatments with potentially curative result for patients with severe genetic diseases.

Amsterdam, The Netherlands
Vrijeme pridruživanja: travanj 2012.

Tweetovi

Blokirali ste korisnika/cu @uniQure_NV

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @uniQure_NV

  1. prije 9 sati

    Patients that test positive for pre-existing anti-AAV5 antibodies can still benefit from AAV5-based . Our poster on the topic was recognized as a top scoring abstract at . Come by tonight's poster session to learn more!

    Poništi
  2. prije 10 sati

    uniQure will have six presentations at this evening’s poster session, beginning at 18:30 CET. You can access all six posters now on our website.

    Poništi
  3. prije 12 sati

    Our symposium “The Comprehensive Care Team and : Continuing the Patient Focus” begins today at 5:15 CET. If you’re in attendance at , join us for a discussion of best communication practices between HCPs and patients.

    Poništi
  4. prije 16 sati

    We’re happy to have a strong presence at this week’s , held here in our backyard in The Hague, the Netherlands. We’ll be delivering seven presentations on for , including an oral presentation on Friday.

    Poništi
  5. 4. velj

    At today's quarterly uniQure Town Hall, CEO Matt Kapusta reviewed our 2019 successes and laid out plans for what we expect will be a fantastic year ahead as we advance our , , and early-stage programs.

    Poništi
  6. 3. velj

    Heading to in the Netherlands this week? Join us for a symposium to examine, from the patients’ perspective, how patients and HCPs can best communicate in the context of .

    Poništi
  7. 29. sij

    uniQure's Sr. Director of HEOR Nick Li participated in a panel discussion on “Analysis of Current Reimbursement Trends and New Developments in Market Access” - including the new paradigm of - at this week's Patient Registries, Real World Evidence and HEOR Summit.

    Poništi
  8. 23. sij

    We're looking for a VP of Global Marketing to join our Commercial team. This exciting new position will be responsible for setting the strategy and leading all marketing efforts for uniQure's commercial and pipeline products. Learn more and join us!

    Poništi
  9. 20. sij

    uniQure has a thriving Co-Op Program, which gives bright local students an integrated learning experience while providing our teams with valuable help in the lab/office! We welcome this semester's co-op crew, incl. students from , , and .

    Poništi
  10. 17. sij

    As gene therapy becomes a reality in , the need for strong and clear communication becomes critical. At , we're sponsoring a symposium to examine, from the patients’ perspective, the ways patients and HCPs can best communicate in the context of .

    Poništi
  11. 16. sij

    Over pizza and salad, our employees learned about Health Economics and Outcomes Research and its role in understanding the clinical value and economic impact of , as healthcare prepares for the transformative impact of these potentially curative new treatments.

    Poništi
  12. 13. sij

    uniQure is kicking off the JP Morgan Conference with an investor breakfast moderated by analyst Debjit Chattopadhyay, where we're discussing our plans to advance our candidates to patients.

    Poništi
  13. 10. sij

    Looking forward to heading west for next week's JP Morgan Healthcare Conference, where we'll be meeting with investors and analysts and discussing our top priorities for 2020 at the year's biggest industry meeting.

    Poništi
  14. 19. pro 2019.

    Announces Publication of Preclinical Data for in ’s Disease Supporting Non-Selective HTT-Lowering Approach:

    Poništi
  15. 16. pro 2019.

    Today we welcomed patient advocate Cheryl Sullivan Staveley, who shared the story of the impact HD has had on her family. As we work on AMT-130, we are inspired to do all that we can to deliver a desperately-needed treatment to those with HD.

    Poništi
  16. 14. pro 2019.

    uniQure VP of Research Pavlina Konstantinova presented our clinical trial at today's Lega Italiana Ricerca Huntington meeting, where hundreds of Italian patients, artists, scientists, and HCPs discussed the latest developments in treatment.

    Poništi
  17. 13. pro 2019.

    uniQure EVP Sander van Deventer moderated a discussion on advancements toward AAV for CNS diseases such as and at this week's GTxN - Gene Therapy for Neurological Disorders Summit in Boston.

    Poništi
  18. 12. pro 2019.

    The presents are wrapped with care for our Yankee Swap at tonight's Holiday Party in Lexington, Mass. Happy Holidays from uniQure!

    Poništi
  19. 10. pro 2019.

    ICYMI, the recording of the investor webcast reviewing the data on our is now available.

    Poništi
  20. 9. pro 2019.

    Dr. Pipe discussing the functionally curative levels of Factor IX activity seen in the three patients in our Ph. 2b study of EtranaDez (AMT-061), our for patients with , at this morning's investor webcast.

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·